CECS, I-Stem, Corbeil-Essonne 91100, France; INSERM U861, I-Stem, Corbeil-Essonne 91100, France; UEVE U861, I-Stem, Corbeil-Essonne 91100, France; Genethon, 91000 Evry, France; Université Paris-Saclay, Univ Evry, Inserm, Genethon, Integrare research Unit UMR_S951, 91000 Evry, France.
CECS, I-Stem, Corbeil-Essonne 91100, France; INSERM U861, I-Stem, Corbeil-Essonne 91100, France; UEVE U861, I-Stem, Corbeil-Essonne 91100, France.
Stem Cell Res. 2023 Oct;72:103214. doi: 10.1016/j.scr.2023.103214. Epub 2023 Sep 23.
Glycogen storage disease type III (GSDIII) is an autosomal recessive disorder characterized by a deficiency of glycogen debranching enzyme (GDE) leading to cytosolic glycogen accumulation and inducing liver and muscle pathology. Skin fibroblasts from three GSDIII patients were reprogrammed into induced pluripotent stem cells (iPSCs) using non-integrated Sendai virus. All of the three lines exhibited normal morphology, expression of pluripotent markers, stable karyotype, potential of trilineage differentiation and absence of GDE expression, making them valuable tools for modeling GSDIII disease in vitro, studying pathological mechanisms and investigating potential treatments.
糖原贮积病 III 型(GSDIII)是一种常染色体隐性遗传疾病,其特征是糖原分支酶(GDE)缺乏,导致细胞质糖原积累,并引起肝脏和肌肉病理学改变。使用非整合性仙台病毒将 3 名 GSDIII 患者的皮肤成纤维细胞重编程为诱导多能干细胞(iPSC)。这 3 条线均表现出正常形态、多能标志物表达、稳定的核型、三系分化潜能和 GDE 表达缺失,使它们成为在体外模拟 GSDIII 疾病、研究病理机制和研究潜在治疗方法的有价值工具。